Assoc. Prof. Dr. Álvaro Castellanos, HOSPITAL UNIVERSITARIO Y POLITÉCNICO LA FE DE VALENCIA, Spain
Dr. Álvaro Castellanos Ortega is a highly esteemed Associate Professor of Medicine and the Head of the Intensive Care Department at Hospital Universitario y Politécnico La Fe in Valencia. He earned his Medical degree from the University of Valladolid and completed his PhD at the University of Cantabria. With extensive expertise in intensive care and medical education, Dr. Castellanos has contributed significantly to research in infection, sepsis, and training. He has authored 63 indexed publications, and his work on competence-based medical education has earned multiple prestigious awards, including the ESICM Trials Group Award. He is also actively involved in European medical education initiatives.
Publication Profile
Orcid
Professional Qualifications 🏥
Assoc. Prof. Dr. Álvaro Castellanos is a distinguished medical professional with a strong academic and clinical background. He graduated in Medicine and Surgery from the University of Valladolid (1979) and earned his PhD with honors from the University of Cantabria (1998), focusing on a prognostic scoring system for meningococcal septic shock in children. He specialized in Intensive Care Medicine, completing his training at Hospital Universitario Marqués de Valdecilla. Dr. Castellanos serves as Head of the Intensive Care Medicine Department at Hospital Universitario y Politécnico La Fe de Valencia. He is also an Associate Professor at the University of Valencia and an EDIC examiner. Additionally, he holds a Master’s in Healthcare Administration from the University of Cantabria. 🌟
Awards and Recognitions
Assoc. Prof. Dr. Álvaro Castellanos has earned numerous prestigious awards throughout his career. He won the First Prize for Quality Improvement of Care from the Regional Healthcare Service of Cantabria in 2008. His initiative on implementing the Surviving Sepsis Campaign during residency also received recognition. In 2017, he earned the First Prize for Best Patient Safety Initiatives for his rapid response system project. Dr. Castellanos was awarded the Best Project in Postgraduate Teaching by the Lilly Foundation for his electronic portfolio for specialists. Additionally, he received the ESICM Trials Group Award for his research on medical education in intensive care. 🌟
Research Focus
Dr. Álvaro Castellanos-Ortega is an Associate Professor with significant contributions in intensive care medicine, particularly related to medical education and patient safety in critically ill patients. He has been involved in multiple research projects focusing on pharmacokinetics in critically ill patients, including studies on Cefiderocol, Isavuconazole, and other medications. Dr. Castellanos-Ortega has authored and co-authored numerous articles on intensive care topics such as COVID-19 management, heart transplantation, and training programs for intensive care medicine. His work is widely published in journals like Medicina Intensiva and Critical Care, contributing significantly to the improvement of clinical practices in intensive care units.
Publication Top Notes
- Effect of a Competence-Based Medical Education Program on Training Quality in Intensive Care Medicine. COBALIDATION TRIAL.
Medicina Intensiva (2025-01-03)
DOI: 10.1016/j.medine.2024.502126
PMID: 39755447
Contributors: Castellanos-Ortega Á, Broch Porcar MJ, Palacios-Castañeda D, et al.
- Cefiderocol Pharmacokinetics in Critically Ill Patients Undergoing ECMO Support.
Critical Care (2024-10-18)
DOI: 10.1186/s13054-024-05126-4
PMID: 39425201
PMC: PMC11488226
Contributors: Marín-Cerezuela M, Martín-Latorre R, Frasquet J, et al.
- Reply to “Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?”
Medicina Intensiva (2024-10-05)
DOI: 10.1016/j.medine.2024.07.013
PMID: 39368886
Contributors: Broch Porcar MJ, Castellanos-Ortega Á
- Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends Over Time.
Biomedicines (2024-09-16)
DOI: 10.3390/biomedicines12092109
PMID: 39335622
PMC: PMC11428817
Contributors: López Vilella R, Pérez Guillén M, Borja Guerrero Cervera, et al.
- Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Antibiotics (2024-07-29)
DOI: 10.3390/antibiotics13080706
PMID: 39200006
PMC: PMC11350865
Contributors: Martín Cerezuela M, Gallegos C, Marqués-Miñana MR, et al.
- Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?
Medicina Intensiva (2024-05-25)
DOI: 10.1016/j.medine.2024.04.012
PMID: 38797620
Contributors: Broch Porcar MJ, Castellanos-Ortega Á
- “INTUPROS”: An Opportunity to Reflect Upon and Improve.
Medicina Intensiva (2024-05-06)
DOI: 10.1016/j.medine.2024.04.014
PMID: 38714391
Contributors: Viviani A, Vicent C, Castellanos-Ortega Á
- Mentoring Programme: Guiding Your First Steps Towards Scientific Excellence.
Medicina Intensiva (2023-03-21)
DOI: 10.1016/j.medine.2023.03.006
PMID: 36948924
Contributors: Lobo-Valbuena B, Galarza Barrachina L, Albillos Almaraz R, et al.
- Effects of Intubation Timing in Patients with COVID-19 Throughout the Four Waves of the Pandemic: A Matched Analysis.
The European Respiratory Journal (2023-03-02)
DOI: 10.1183/13993003.01426-2022
PMID: 36396142
PMC: PMC9686319
Contributors: Riera del Brio J, Barbeta E, Tormos A, et al.
- Driving Pressure and Adjunctive Therapies in Pulmonary Sequelae of COVID-19 Patients Under Invasive Ventilation.
Intensive Care Medicine (2023-01-25)
DOI: 10.1007/s00134-022-06951-3
PMID: 36695836
PMC: PMC9875751
Contributors: González J, Iván David Benítez, Ana Motos, et al.